November 15, 2021 11:17 AM ESTUpdated 03:52 PM

AstraZeneca, Moderna start to raise the curtain on a new mRNA heart drug — but efficacy will have to wait

Amber Tong

Can injecting messenger RNA directly into the heart of patients who’ve experienced heart failure help repair the organ? More than three years after AstraZeneca and …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

AstraZeneca, Moderna start to raise the curtain on a new mRNA heart drug — but efficacy will have to wait

Amber Tong

Sign up to read this article for free.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

FDA inspectors discover trucks carrying torn-up records leaving Indian generics factory

Aligos’ trial for oral MASH treatment succeeds, but placebo group shows odd trend

Lasker Award goes to three scientists who pioneered research behind GLP-1 drugs

Roche outlines commercial manufacturing strategy for GLP-1/GIP assets

Exclusive: Flagship-backed Valo Health loses interim CEO ahead of key Phase 2 readout

Breaking down silos with a new quantitative approach to drug development

As­traZeneca, Mod­er­na start to raise the cur­tain on a new mR­NA heart drug — but ef­fi­ca­cy will have to wait

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

AstraZeneca, Moderna start to raise the curtain on a new mRNA heart drug — but efficacy will have to wait